Researchers have been excited about the medication , a novel dual agonist showing promising data in clinical trials for size reduction . It functions by impacting both hormones : GLP-1 and GIP, that , https://jaysonoksb069690.blogaritma.com/38705672/a-new-prospect-for-weight-loss